Skip to content

Bio-Techne

US · TECH #1365 by market cap Listed 1970
72.67 -0.03 -0.04%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Price chart

Pre-market 72.76 +0.08%
After-hours 72.67 0.00%
72.8047.8672.672026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on TECH?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +12.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 4.9% of float.
  • Analyst tilt is Sell.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 02:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall B

The radar needs all six factors. Available grades are shown below.

Valuation D-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 66.1x Better than 6%
Forward P/E 55.6x Better than 6%
Price / Sales 9.3x Better than 11%
P/E vs own 5-yr range 57th pctl Better than 53%
Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 2.2% Better than 36%
Net income CAGR (3Y) -13.9% Better than 23%
Free cash flow CAGR (3Y) 6.8% Better than 48%
Profitability B+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 65.8% Better than 79%
Operating margin 22.4% Better than 81%
Net margin 15.0% Better than 71%
Return on equity 9.0% Better than 48%
Return on invested capital 7.8% Better than 59%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 0.7% Better than 75%
6-month return 51.1% Better than 95%
12-month return (ex latest month) 18.4% Better than 57%
Distance below 52-week high 0.3% Better than 99%
Financial Health A

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 4.5x Better than 84%
Debt to assets 11.2% Better than 67%
Interest coverage 26.0x Better than 85%
Free cash flow / net income 144.7% Better than 64%
Analyst View N/A

What the Street thinks: share of Buy ratings and upside to the average target.

Not enough data to grade this factor.

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -0.18%
1M +0.23%
3M +0.76%
6M +55.95%
YTD +24.24%
1Y +24.41%
3Y +16.05%
5Y -40.67%

Key statistics

Price & volume

Prev close
72.70
Open
72.74
Day range
72.66 - 72.77
Avg price
72.72
Volume
3.66M
Turnover
266.39M
Amplitude
0.14%
52-week range
43.02 - 72.86

Valuation

P/E
62.65
P/E (TTM)
66.06
P/B
5.27
EPS
1.16
Net profit
182.23M
Net assets
2.17B

Share structure

Market cap
11.42B
Float cap
11.36B
Shares out
157.09M
Float shares
156.38M

Dividend & listing

Dividend (TTM)
0.32
Listing date
1970-01-01
52-week range 99% of range
43.02 72.86

0.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-76.91M net over the window

Short interest

Shares short
7.70M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Bio-Techne (TECH)?

Bio-Techne last traded at 72.67. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Bio-Techne's market cap?

About 11.42B.

What is the P/E ratio of Bio-Techne?

The trailing twelve-month P/E is 66.06, below its own 5-year average of 70.51 — in the middle of its historical range (56.62% percentile). See the Valuation tab for the full history.

Does Bio-Techne pay a dividend?

Yes. The trailing dividend yield is 0.44%. Per-share dividends have risen or held for 11 straight years through 2025. See the Dividends tab for the full payment history.

Is Bio-Techne a buy according to analysts?

The consensus of 2 analysts is a Sell rating, with an average 12-month price target of 73.00, which implies 0.5% upside from the current price. This is not investment advice.

What is Bio-Techne's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Bio-Techne a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:01:25 · For reference only, not investment advice and not tailored to your situation.

Bio-Techne discussion 0 comments

Add a comment